Key Details
Price
$57.09PE Ratio
13.59Annual ROE
54.39%Beta
-Events Calendar
Next earnings date:
May 7, 2025Recent quarterly earnings:
Feb 21, 2025Recent annual earnings:
Feb 21, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 11, 25 Truist Securities
BuyMar 11, 25 HC Wainwright & Co.
BuyMar 11, 25 BMO Capital
OutperformMar 10, 25 HC Wainwright & Co.
BuyMar 10, 25 Citizens Capital Markets
Market OutperformMar 4, 25 JP Morgan
OverweightMar 3, 25 HC Wainwright & Co.
BuyFeb 24, 25 HC Wainwright & Co.
BuyFeb 24, 25 Goldman Sachs
NeutralFeb 7, 25 JMP Securities
Market OutperformMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Protagonist Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Protagonist Therapeutics?
- Does Protagonist Therapeutics pay dividends?
- What sector is Protagonist Therapeutics in?
- What industry is Protagonist Therapeutics in?
- What country is Protagonist Therapeutics based in?
- When did Protagonist Therapeutics go public?
- Is Protagonist Therapeutics in the S&P 500?
- Is Protagonist Therapeutics in the NASDAQ 100?
- Is Protagonist Therapeutics in the Dow Jones?
- When was Protagonist Therapeutics's last earnings report?
- When does Protagonist Therapeutics report earnings?
- Should I buy Protagonist Therapeutics stock now?
What is the ticker symbol for Protagonist Therapeutics?
The ticker symbol for Protagonist Therapeutics is NASDAQ:PTGX
Does Protagonist Therapeutics pay dividends?
No, Protagonist Therapeutics does not pay dividends
What sector is Protagonist Therapeutics in?
Protagonist Therapeutics is in the Healthcare sector
What industry is Protagonist Therapeutics in?
Protagonist Therapeutics is in the Biotechnology industry
What country is Protagonist Therapeutics based in?
Protagonist Therapeutics is headquartered in United States
When did Protagonist Therapeutics go public?
Protagonist Therapeutics's initial public offering (IPO) was on August 11, 2016
Is Protagonist Therapeutics in the S&P 500?
No, Protagonist Therapeutics is not included in the S&P 500 index
Is Protagonist Therapeutics in the NASDAQ 100?
No, Protagonist Therapeutics is not included in the NASDAQ 100 index
Is Protagonist Therapeutics in the Dow Jones?
No, Protagonist Therapeutics is not included in the Dow Jones index
When was Protagonist Therapeutics's last earnings report?
Protagonist Therapeutics's most recent earnings report was on Feb 21, 2025
When does Protagonist Therapeutics report earnings?
The next expected earnings date for Protagonist Therapeutics is May 7, 2025
Should I buy Protagonist Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions